NO955258L - Medisinsk anvendelse av enzymer - Google Patents

Medisinsk anvendelse av enzymer

Info

Publication number
NO955258L
NO955258L NO955258A NO955258A NO955258L NO 955258 L NO955258 L NO 955258L NO 955258 A NO955258 A NO 955258A NO 955258 A NO955258 A NO 955258A NO 955258 L NO955258 L NO 955258L
Authority
NO
Norway
Prior art keywords
enzymes
medical use
enzyme
cyclic nucleotide
nucleotide pathways
Prior art date
Application number
NO955258A
Other languages
English (en)
Norwegian (no)
Other versions
NO955258D0 (no
Inventor
Tracey Lehanne Mynott
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Publication of NO955258D0 publication Critical patent/NO955258D0/no
Publication of NO955258L publication Critical patent/NO955258L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO955258A 1993-06-25 1995-12-22 Medisinsk anvendelse av enzymer NO955258L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939313188A GB9313188D0 (en) 1993-06-25 1993-06-25 Medical use of enzymes
PCT/GB1994/001368 WO1995000169A1 (en) 1993-06-25 1994-06-24 Medical use of stem bromelain protease

Publications (2)

Publication Number Publication Date
NO955258D0 NO955258D0 (no) 1995-12-22
NO955258L true NO955258L (no) 1996-02-22

Family

ID=10737823

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955258A NO955258L (no) 1993-06-25 1995-12-22 Medisinsk anvendelse av enzymer

Country Status (11)

Country Link
US (1) US5824305A (ja)
EP (1) EP0713396A1 (ja)
JP (1) JPH08511687A (ja)
AU (1) AU681891B2 (ja)
CA (1) CA2165787A1 (ja)
FI (1) FI956178L (ja)
GB (1) GB9313188D0 (ja)
NO (1) NO955258L (ja)
NZ (1) NZ267660A (ja)
SG (1) SG42309A1 (ja)
WO (1) WO1995000169A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412711D0 (en) * 1994-06-24 1994-08-17 Cortecs Ltd Medical use of bromelain
EP1012305A1 (en) * 1997-02-25 2000-06-28 Cortecs (UK) Limited Component of bromelain
US20020102253A1 (en) 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
US6413512B1 (en) * 1998-02-13 2002-07-02 National Enzyme Company Composition and method for treating disease by increasing activated α2 macroglobulin in the blood and extravascular tissue
CA2333252C (en) 1998-07-15 2008-11-25 Ursapharm Arzneimittel Gmbh Use of bromelain proteases for inhibiting blood coagulation
GB9819137D0 (en) * 1998-09-02 1998-10-28 Cortecs Uk Ltd Component of bromelain
US6130053A (en) * 1999-08-03 2000-10-10 Cell Pathways, Inc. Method for selecting compounds for inhibition of neoplastic lesions
IL165334A0 (en) * 2004-11-22 2006-01-15 Mediwound Ltd Debriding composition from bromelain and methods of producing same
WO2007047205A2 (en) * 2005-10-11 2007-04-26 Amano Enzyme Usa Co., Ltd. Enzyme inhibitors of pai-1
EP2036978A1 (en) * 2007-09-14 2009-03-18 URSAPHARM Arzneimittel GmbH & Co. KG Recombinant preparation of selected bromelain fractions
CN108472341A (zh) * 2015-08-20 2018-08-31 安纳塔拉生命科学有限公司 具有抗炎活性的酶级分
RU2732224C9 (ru) 2016-01-31 2021-06-18 Медивунд Лтд. Раноочищающая композиция для лечения ран

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197291A (en) * 1974-01-08 1980-04-08 Gerold K. V. Klein Hydrolytic enzyme material
GB8821049D0 (en) * 1988-09-08 1988-10-05 Health Lab Service Board Method & composition for treatment & prevention of viral infections
RU2113220C1 (ru) * 1991-07-24 1998-06-20 Энзакор Пропертиз Лимитед Композиция, способ лечения кишечной инфекции, способ неспецифической стимуляции имvунной системы, способ доставки биологически активного материала в верхние отделы тонкого кишечника
DK0671943T3 (da) * 1992-06-30 2000-03-27 Cortecs Uk Ltd Anvendelse af enzymer, især bromelain, i behandlingen af ikke-infektiøs diarré

Also Published As

Publication number Publication date
FI956178A7 (fi) 1996-02-21
FI956178L (fi) 1996-02-21
AU7002794A (en) 1995-01-17
AU681891B2 (en) 1997-09-11
CA2165787A1 (en) 1995-01-05
SG42309A1 (en) 1997-08-15
NO955258D0 (no) 1995-12-22
NZ267660A (en) 1997-05-26
GB9313188D0 (en) 1993-08-11
WO1995000169A1 (en) 1995-01-05
JPH08511687A (ja) 1996-12-10
FI956178A0 (fi) 1995-12-21
EP0713396A1 (en) 1996-05-29
US5824305A (en) 1998-10-20

Similar Documents

Publication Publication Date Title
NO944997L (no) Trombin-blodfraksjon for anvendelse ved en medisinsk fremgangsmåte
MY129998A (en) Saccharin derivative proteolytic enzyme inhibitors
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
NO961888D0 (no) Peptidylforbindelser og deres terapeutiske anvendelse som inhibitorer av metallproteinaser
NO955258L (no) Medisinsk anvendelse av enzymer
DE3785036D1 (de) Verwendung katabolischer enzyme zur herstellung eines medikaments zum bekaempfen der erworbenen immunschwaeche (aids) und deren vorstadien (las, arc).
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
AU5325686A (en) Vectors and method for expression of human protein c activity
AU2275397A (en) Troponin subunits and fragments useful as angiogenesis inhibitors
BG100455A (en) Hiv protease inhibitors
KR960705815A (ko) 신규한 피라진 카복스아미드 유도체, 이의 제조방법 및 약제에 있어서의 이의 용도(Novel pyrazine carboxamide derivatives, their production and their use in medicaments)
DK0470136T3 (da) Terapeutisk middel
DK0688362T3 (da) Kloning og rekombinant fremstilling af vespidgiftenzymer, såsom phospholipase og hyaluronidase, og immunologiske terapier baseret derpå
ES2125976T3 (es) Otros derivados de indol con accion antiviral.
HUP0004544A2 (hu) Angiotenzin-átalakító enzim inhibitora és diuretikum kombinációjának alkalmazása mikrokeringési rendellenességek kezelésére szolgáló gyógyászati készítmény előállítására
NO965564L (no) Medisinsk anvendelse av bromelain
ATE277943T1 (de) Trypsininhibitoren
ATE315558T1 (de) Verbindungen mit cytochrom p450ra1 hemmenden aktivität
IL123001A0 (en) Analgesic from snake venom
AU3206297A (en) Composition and method for treating herpes simplex
ATE119780T1 (de) Katabolische enzyme zur induktion des tumornekrose-faktors (tnf).
DK0673425T3 (da) DNA kodning for chitin deacetylase
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
DE69332904D1 (de) Hemmung von hiv-infektion
NZ515727A (en) Aminotetralin derivative for the therapy of cardiovascular diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application